UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049862
Receipt number R000056793
Scientific Title Evaluation of cardiotoxicity using cardiac MRI in patients treated with IMRT and establishment of cardiac dose constraints
Date of disclosure of the study information 2022/12/26
Last modified on 2022/12/21 20:35:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of cardiotoxicity using cardiac MRI in patients treated with IMRT and establishment of cardiac dose constraints

Acronym

Evaluation of cardiotoxicity using cardiac MRI in patients treated with IMRT and establishment of cardiac dose constraints

Scientific Title

Evaluation of cardiotoxicity using cardiac MRI in patients treated with IMRT and establishment of cardiac dose constraints

Scientific Title:Acronym

Evaluation of cardiotoxicity using cardiac MRI in patients treated with IMRT and establishment of cardiac dose constraints

Region

Japan


Condition

Condition

esophageal cancer, lung cancer, malignant lymphoma

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to demonstrate the effects of radiotherapy (conventional irradiation, IMRT) on cardiac toxicity using cardiac MRI in patients treated with radiotherapy for malignant tumors in the thoracic region.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

MR strain, Native T1

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Cardiac MRI examinations will be performed 3 times in total: before radiotherapy, 4 months after radiotherapy, and 1 year after radiotherapy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Performance status 0-1, patients with written informed consent, patients for whom MRI examination can be safely performed

Key exclusion criteria

Patients with a history of ischemic heart disease, patients with abnormal signals of heart disease in cardiac MRI before radiotherapy, patients with a history of radiotherapy to the chest, patients with uncontrolled diabetes and hypertension

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shintaro
Middle name
Last name Tsuruoka

Organization

Ehime University Graduate School of Medicine

Division name

Department of Radiology

Zip code

791-0295

Address

Shitsukawa, Toon, Ehime

TEL

089-960-5371

Email

tsuruoka.shintaro.az@ehime-u.ac.jp


Public contact

Name of contact person

1st name Shintaro
Middle name
Last name Tsuruoka

Organization

Ehime University Graduate School of Medicine

Division name

Department of Radiology

Zip code

791-0295

Address

Shitsukawa, Toon, Ehime

TEL

089-960-5371

Homepage URL


Email

tsuruoka.shintaro.az@ehime-u.ac.jp


Sponsor or person

Institute

Ehime University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ehime University Hospital

Address

454 Shitsukawa, Toon, Ehime

Tel

089-964-5111

Email

tsuruoka.shintaro.az@ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 07 Month 01 Day

Date of IRB

2022 Year 07 Month 25 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 21 Day

Last modified on

2022 Year 12 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056793


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name